GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 424 filers reported holding GLOBUS MED INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $22,831,923 | -33.5% | 383,472 | -36.7% | 0.08% | -43.9% |
| Q1 2023 | $34,321,065 | +6791.8% | 605,951 | +6736.1% | 0.15% | +3600.0% |
| Q2 2022 | $498,000 | -34.3% | 8,864 | -13.8% | 0.00% | -33.3% |
| Q1 2022 | $758,000 | +28.5% | 10,278 | +25.8% | 0.01% | +20.0% |
| Q4 2021 | $590,000 | -78.2% | 8,169 | -76.8% | 0.01% | -85.3% |
| Q3 2021 | $2,703,000 | +64.9% | 35,283 | +32.7% | 0.03% | +30.8% |
| Q1 2021 | $1,639,000 | +38.5% | 26,585 | +46.6% | 0.03% | +52.9% |
| Q4 2020 | $1,183,000 | -66.8% | 18,137 | -74.8% | 0.02% | -66.7% |
| Q3 2020 | $3,560,000 | -2.5% | 71,899 | -6.0% | 0.05% | -5.6% |
| Q2 2020 | $3,651,000 | +668.6% | 76,528 | +849.2% | 0.05% | +260.0% |
| Q4 2019 | $475,000 | +246.7% | 8,062 | +234.0% | 0.02% | -16.7% |
| Q3 2018 | $137,000 | +756.2% | 2,414 | +640.5% | 0.02% | +80.0% |
| Q2 2018 | $16,000 | – | 326 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sterling Investment Advisors, Ltd. | 197,873 | $11,109,000 | 3.82% |
| Pembroke Management, LTD | 600,148 | $33,692,000 | 3.48% |
| Godshalk Welsh Capital Management, Inc. | 73,101 | $4,104,000 | 2.95% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 688,000 | $38,624,000 | 2.62% |
| XXEC, Inc. | 50,625 | $2,842,000 | 2.26% |
| Van Berkom & Associates Inc. | 885,922 | $49,736,000 | 2.08% |
| GENEVA CAPITAL MANAGEMENT LLC | 1,351,998 | $75,901,000 | 1.75% |
| RTW INVESTMENTS, LP | 1,121,527 | $62,963,000 | 1.63% |
| Global Alpha Capital Management Ltd. | 257,131 | $14,435,000 | 1.56% |
| Ophir Asset Management Pty Ltd | 258,889 | $6,622,381,000 | 1.36% |